Literature DB >> 14293424

KINETICS OF MEPROBAMATE ELIMINATION IN HUMANS.

L E HOLLISTER, G LEVY.   

Abstract

Entities:  

Keywords:  BLOOD; DRUG THERAPY; MEPROBAMATE; METABOLISM

Mesh：

Substances：

Year:  1964        PMID： 14293424     DOI： 10.1159/000220338

Source DB:  PubMed          Journal:  Chemotherapia (Basel)        ISSN： 0366-7170


× No keyword cloud information.
  5 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.

Authors:  Manish Kumar; Glenn H Dillon
Journal:  Eur J Pharmacol       Date:  2016-02-09       Impact factor: 4.432

Review 3.  Pharmacokinetic evaluation of hemodialysis in acute drug overdose.

Authors:  S Takki; J G Gambertoglio; D H Honda; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

Review 4.  Clinical use of psychotherapeutic drugs. II. Antidepressant and antianxiety drugs and special problems in the use of psychotherapeutic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  [Pharmacokinetics of meprobamate in chronic liver diseases and drug addiction].

Authors:  H Held; H F von Oldershausen
Journal:  Klin Wochenschr       Date:  1969-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.